124 related articles for article (PubMed ID: 30522558)
1. Retinoic acid increases the anticancer effect of paclitaxel by inducing differentiation of cancer stem cells in melanoma.
Wang YB; Sun B; Han B
Pharmazie; 2018 Dec; 73(12):729-732. PubMed ID: 30522558
[TBL] [Abstract][Full Text] [Related]
2. Dual-Blocking of PI3K and mTOR Improves Chemotherapeutic Effects on SW620 Human Colorectal Cancer Stem Cells by Inducing Differentiation.
Kim MJ; Koo JE; Han GY; Kim B; Lee YS; Ahn C; Kim CW
J Korean Med Sci; 2016 Mar; 31(3):360-70. PubMed ID: 26955235
[TBL] [Abstract][Full Text] [Related]
3. ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets.
Luo Y; Dallaglio K; Chen Y; Robinson WA; Robinson SE; McCarter MD; Wang J; Gonzalez R; Thompson DC; Norris DA; Roop DR; Vasiliou V; Fujita M
Stem Cells; 2012 Oct; 30(10):2100-13. PubMed ID: 22887839
[TBL] [Abstract][Full Text] [Related]
4. SOX2 upregulates side population cells and enhances their chemoresistant ability by transactivating ABCC1 expression contributing to intrinsic resistance to paclitaxel in melanoma.
Si X; Gao Z; Xu F; Zheng Y
Mol Carcinog; 2020 Mar; 59(3):257-264. PubMed ID: 31883360
[TBL] [Abstract][Full Text] [Related]
5. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
[TBL] [Abstract][Full Text] [Related]
6. Coating Solid Lipid Nanoparticles with Hyaluronic Acid Enhances Antitumor Activity against Melanoma Stem-like Cells.
Shen H; Shi S; Zhang Z; Gong T; Sun X
Theranostics; 2015; 5(7):755-71. PubMed ID: 25897340
[TBL] [Abstract][Full Text] [Related]
7. Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells.
Sun R; Liu Y; Li SY; Shen S; Du XJ; Xu CF; Cao ZT; Bao Y; Zhu YH; Li YP; Yang XZ; Wang J
Biomaterials; 2015 Jan; 37():405-14. PubMed ID: 25453968
[TBL] [Abstract][Full Text] [Related]
8. Berberis libanotica Ehrenb extract shows anti-neoplastic effects on prostate cancer stem/progenitor cells.
El-Merahbi R; Liu YN; Eid A; Daoud G; Hosry L; Monzer A; Mouhieddine TH; Hamade A; Najjar F; Abou-Kheir W
PLoS One; 2014; 9(11):e112453. PubMed ID: 25380390
[TBL] [Abstract][Full Text] [Related]
9. Differentiation therapy: targeting human renal cancer stem cells with interleukin 15.
Azzi S; Bruno S; Giron-Michel J; Clay D; Devocelle A; Croce M; Ferrini S; Chouaib S; Vazquez A; Charpentier B; Camussi G; Azzarone B; Eid P
J Natl Cancer Inst; 2011 Dec; 103(24):1884-98. PubMed ID: 22043039
[TBL] [Abstract][Full Text] [Related]
10. New ferrocene modified retinoic acid with enhanced efficacy against melanoma cells
Wang Y; Sun B; Han B; Hu M
RSC Adv; 2018 Aug; 8(49):27740-27745. PubMed ID: 35542710
[TBL] [Abstract][Full Text] [Related]
11. AS602801, an Anticancer Stem Cell Candidate Drug, Reduces Survivin Expression and Sensitizes A2780 Ovarian Cancer Stem Cells to Carboplatin and Paclitaxel.
Yamamoto M; Suzuki S; Togashi K; Sanomachi T; Seino S; Kitanaka C; Okada M
Anticancer Res; 2018 Dec; 38(12):6699-6706. PubMed ID: 30504379
[TBL] [Abstract][Full Text] [Related]
12. [All-trans retinoic acid effectively inhibits breast cancer stem cells growth in vitro].
Zeng WG; Hu P; Wang JN; Liu RB
Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):89-93. PubMed ID: 23714660
[TBL] [Abstract][Full Text] [Related]
13. A Small-molecule Kinase Inhibitor, CEP-1347, Inhibits Survivin Expression and Sensitizes Ovarian Cancer Stem Cells to Paclitaxel.
Togashi K; Okada M; Yamamoto M; Suzuki S; Sanomachi T; Seino S; Yamashita H; Kitanaka C
Anticancer Res; 2018 Aug; 38(8):4535-4542. PubMed ID: 30061219
[TBL] [Abstract][Full Text] [Related]
14. Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid.
Friedman MD; Jeevan DS; Tobias M; Murali R; Jhanwar-Uniyal M
Oncol Rep; 2013 Oct; 30(4):1645-50. PubMed ID: 23877261
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism and cytotoxicity of allicin and all-trans retinoic acid against CD44
Jobani BM; Najafzadeh N; Mazani M; Arzanlou M; Vardin MM
Phytomedicine; 2018 Sep; 48():161-169. PubMed ID: 30195874
[TBL] [Abstract][Full Text] [Related]
16. Suppression of Nrf2 Activity by Chestnut Leaf Extract Increases Chemosensitivity of Breast Cancer Stem Cells to Paclitaxel.
Woo Y; Oh J; Kim JS
Nutrients; 2017 Jul; 9(7):. PubMed ID: 28718813
[TBL] [Abstract][Full Text] [Related]
17. Global analysis of gene expression changes during retinoic acid-induced growth arrest and differentiation of melanoma: comparison to differentially expressed genes in melanocytes vs melanoma.
Estler M; Boskovic G; Denvir J; Miles S; Primerano DA; Niles RM
BMC Genomics; 2008 Oct; 9():478. PubMed ID: 18847503
[TBL] [Abstract][Full Text] [Related]
18. Redox control of retinoic acid receptor activity: a novel mechanism for retinoic acid resistance in melanoma cells.
Demary K; Wong L; Liou JS; Faller DV; Spanjaard RA
Endocrinology; 2001 Jun; 142(6):2600-5. PubMed ID: 11356710
[TBL] [Abstract][Full Text] [Related]
19. Antrodia cinnamomea sensitizes radio-/chemo-therapy of cancer stem-like cells by modulating microRNA expression.
Su YK; Shih PH; Lee WH; Bamodu OA; Wu ATH; Huang CC; Tzeng YM; Hsiao M; Yeh CT; Lin CM
J Ethnopharmacol; 2017 Jul; 207():47-56. PubMed ID: 28602756
[TBL] [Abstract][Full Text] [Related]
20. [Molecular mechanism of chemosensitization to paclitaxel in human melanoma cells induced by targeting the EGFR signaling pathway].
Zhang XJ; Zhang L; Liu YP; Xu HM; Sun P; Song JG; Luo YH
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):181-6. PubMed ID: 23879997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
